Zaire Franklin

Linebacker

Age: 28
Free Agency: 2028 (UFA)
Accrued Seasons: 6
  • 2024 Salary Cap Charge: $8,610,000 (3.31% of cap)
  • 2024 Cash Payout: $12,390,000 (5.04% of spending)
  • 2024 Cash to Cap Ratio: 1.44
  • Contract Value: $31,260,000 ($10,420,000 APY)
  • Fully Guaranteed Money: $17,620,000
  • Contract Ranking: 8/216 at LB

Current Contract

(Extension, signed 2024)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
RegularPer Game
202428$2,880,000$1,250,000$4,000,000$510,000$6,880,000$8,610,0003.3%
202529$5,740,000$1,250,000$0$510,000$5,740,000$7,500,0002.9%
202630$6,240,000$1,250,000$0$765,000$0$8,255,0002.9%
202731$8,240,000$1,250,000$0$765,000$0$10,255,0003.3%
Total$23,100,000$5,000,000$4,000,000$2,550,000$12,620,000$34,620,000

Contract Notes

Zaire Franklin signed a three year, $31.26 million contract extension with the Colts. $17.62 million is guaranteed including a $5 million signing bonus. There are annual per game bonuses as part of the contract.

 

Cash Flows

- fully earned money
- unearned or partially earned money
$10.4M
$20.8M
$31.3M
2024202520262027
Cash Due$9,000,000$6,250,000$7,005,000$9,005,000
Running Cash$9,000,000$15,250,000$22,255,000$31,260,000
Career Earnings: $14,387,056
Career APY: $2,397,843
Potential Earnings: $44,037,056
Total Guarantees: $21,707,056
Largest Cash Payment: $12,390,000 (2024)
Largest Cap Number: $10,255,000 (2027)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
ColtsDraftedExpired20184$2,547,056$636,764$87,056$2,807,056110.2%$701,764
ColtsUFAExtended20223$10,000,000$3,333,333$4,000,000$6,580,00065.8%$3,290,000
ColtsExtensionActive20243$31,260,000$10,420,000$17,620,000$5,000,00016.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Colts6$14,387,056$2,397,843$9,417,0560.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Colts$480,000$21,764$0$0$0$501,7640.3%$567,056
2019Colts$570,000$21,764$0$0$0$591,7640.2%$570,000
2020Colts$750,000$21,764$0$0$0$771,7640.3%$750,000
2021Colts$920,000$21,764$0$0$0$941,7640.5%$920,000
2022Colts$1,100,000$0$2,000,000$510,000$3,100,000$3,610,0001.7%$3,610,000
2023Colts$2,490,000$0$0$510,000$900,000$3,000,0001.3%$2,970,000
2024Colts$2,880,000$1,250,000$4,000,000$510,000$6,880,000$8,610,0003.3%$12,390,000
2025Colts$5,740,000$1,250,000$0$510,000$5,740,000$7,500,0002.9%$6,250,000
2026Colts$6,240,000$1,250,000$0$765,000$0$8,255,0002.9%$7,005,000
2027Colts$8,240,000$1,250,000$0$765,000$0$10,255,0003.3%$9,005,000
Total$29,410,000$5,087,056$6,000,000$3,570,000$16,620,000$44,037,056$44,037,056

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2018160017.0%52.4%141400001000000
201916000.0%81.3%4200000000000
202016008.3%80.8%7300000000000
2021170018.3%78.8%141500102100000
2022170099.6%39.2%10264317.51266003000
2023160193.0%19.2%107721.57.5336002000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$6,811,000$10,420,000
Injury Adjusted$6,811,000$10,420,000
test
OTC Valuation $3.1M $6.1M $9.2M $12.2M $15.3M APY $3.3M $6.7M $10M $13.3M $16.7M $4,874,000 $3,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.